MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$188,789K
Non Us
$39,761K
Revenue From Contract
With Customer...
$101,965K
Pmo Products
$228,550K
Elevidys
$101,965K
Collaboration and other
$400,288K
(200.22%↑ Y/Y)
Products, net
$330,515K
(-45.95%↓ Y/Y)
Total revenues
$730,803K
(-1.89%↓ Y/Y)
Operating income (loss)
$358,433K
(219.32%↑ Y/Y)
Total cost and
expenses
$372,370K
(-64.37%↓ Y/Y)
Income (loss) before
income tax expense
$343,174K
(189.48%↑ Y/Y)
Other expense, net
-$15,259K
(81.64%↑ Y/Y)
Research and development
$153,960K
(-80.09%↓ Y/Y)
Selling, general and
administrative
$108,951K
(-18.47%↓ Y/Y)
Cost of sales
(excluding amortization of...
$108,768K
(-20.93%↓ Y/Y)
Amortization of in-licensed
rights
$691K
(14.98%↑ Y/Y)
Segment net income
(loss)
$330,959K
(173.96%↑ Y/Y)
Income tax expense
$12,215K
(-80.91%↓ Y/Y)
Back
Back
Income Statement
logo (1) copy-svg
Sarepta Therapeutics, Inc. (SRPT)
logo (1) copy-svg
source: myfinsight.com
Sarepta Therapeutics, Inc. (SRPT)